NCT03870035 is a clinical trial in PCOS, sponsored by Assiut University.

Who is sponsoring NCT03870035?

NCT03870035 is sponsored by Assiut University.

Is NCT03870035 still recruiting?

NCT03870035 is currently status unknown. Last updated 26 April 2019.

Last reviewed 2019-04-26 · How we verify

NCT03870035

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Role of Nesfatin-1 and Nicotinamide in Infertile Women With Polycystic Ovary Syndrome

Status unknown Last updated 26 April 2019

What this trial tests

trial in PCOS in 56 participants. Status unknown.

Timeline

1 May 2019

Primary endpoint
1 April 2020

1 May 2020

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	56
Start date	1 May 2019
Primary completion	1 April 2020
Estimated completion	1 May 2020

Conditions studied

PCOS — all drugs for PCOS →

Sponsor

Assiut University

Who can join

Adults 18 to 40, female only, with PCOS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

evaluation of the potential role of circulating Nesfatin-1 and Nicotinamide in patients with polycystic ovary syndrome. and detection the correlation between Nesfatin-1 and body mass index (BMI), Waist hip ratio (WHR), blood glucose, insulin, insulin resistance, lipid profiles, prolactin, LH, FSH, estrogen, progesterone, testosterone and dopamine.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for PCOS

Currently open trials in the same condition.

NCT06424860 — Fish Oil, Metformin and Heart Health in PCOS · Phase 1 · recruiting
NCT06742710 — Liraglutide Treatment in Obese Infertile PCOS Women · Phase 4 · recruiting
NCT07255911 — Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOS · NA · recruiting
NCT06793072 — Adipokines in Polycystic Ovary Syndrome · recruiting
NCT06591169 — Lifestyle Changes in PCOS with OSA and NAFLD · NA · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03870035 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 26 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03870035.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing